Analysis of motor function and dopamine systems of SAMP6 mouse

Physiology and Behavior

Volumn 96, Issue 3, 2009, Pages 464-469

  Niimi, Kimie ^a,b   Takahashi, Eiki ^b   Itakura, Chitoshi ^b  

^a Brain Science And Life Technology Research Foundation   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

D1; D3; Dopamine; Hyperactivity; Motor coordination deficit; Rotating rod test

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; EXPERIMENTAL TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTATING ROD TEST; SENESCENCE ACCELERATED MOUSE; TRACTION TEST; WIRE HANGING TEST;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CEREBELLUM; DOPAMINE; HOMOVANILLIC ACID; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NEOSTRIATUM; NUCLEUS ACCUMBENS; POSTURAL BALANCE; PROPRIOCEPTION; RECEPTORS, DOPAMINE; ROTAROD PERFORMANCE TEST; SPECIES SPECIFICITY;

EID: 58649088012     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.11.012     Document Type: Article

References (39)

1. Takeda T., Hosokawa M., and Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol 32 (1997) 105-109
2. Matsushita M., Tsuboyama T., Kasai R., Okumura H., Yamamuro T., Higuchi K., et al. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). Am J Pathol 125 (1986) 276-283
3. Jilka R.L., Weinstein R.S., Takahashi K., Parfitt A.M., and Manolagas S.C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 97 (1996) 1732-1740
4. Kasai S., Shimizu M., Matsumura T., Okudaira S., Matsushita M., Tsuboyama T., et al. Consistency of low bone density across bone sites in SAMP6 laboratory mice. J Bone Miner Metab 22 (2004) 207-214
5. Griffin W.S.T., Sheng J.G., and Mrak R.E. Senescence-accelerated overexpression of S100b in brain of SAMP6 mice. Neurobiol Aging 19 (1998) 71-76
6. Niimi K., Takahashi E., and Itakura C. Emotional behavior and expression patterns of tyrosine hydroxylase and tryptphan hydroxylase in senescence-accelerated mouse (SAM) P6 mice. Behav Brain Res 188 (2008) 329-336
7. Niimi K., Takahashi E., and Itakura C. Improved short-term memory and increased expression of NR2B observed in senescence-accelerated mouse (SAM) P6. Exp Gerontol 43 (2008) 847-852
8. Shimano Y. Studies on aging through analysis of the glucose metabolism related to the ATP-production of the senescence accelerated mouse (SAM). Hokkido Igaku Zasshi 73 (1998) 557-569
9. Chen G.H., Wang C., Yangcheng H.Y., Liu R.Y., and Zhou J.N. Age-related changes in anxiety are task-specific in the senescence-accelerated prone mouse 8. Physiol Behav 91 (2007) 644-651
10. Miyamoto M. Experimental techniques for developing new drugs acting on dementia (8) -characteristics of behavioral disorders in senescence-accelerated mouse (SAMP8): possible animal model for dementia. Nihon Shinkei Seishin Yakurigaku Zasshi 14 (1994) 323-335
11. Sanchez-Barcelo E.J., Megias M., Verduga R., and Crespo D. Differences between the circadian system of two strains of senescence-accelerated mice (SAM). Physiol Behav 62 (1997) 1225-1229
12. Asai M., Ikeba M., Akiyama M., Oshima I., and Shibata S. Administration of melatonin in drinking water promotes the phase advance of light-dark cycle in senescence-accelerated mice, SAMR1 but not SAMP8. Brain Res 876 (2000) 220-224
13. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83 (1995) 1197-1209
14. Sei Y., Skolnick P., and Arora P.K. Strain variation in immune response and behavior following the death of cage cohorts. Int J Neurosci 65 (1992) 247-258
15. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 78 (1998) 189-225
16. Ikemoto S., and Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 31 (1999) 6-41
17. Viggiano D., Ruocco L.A., and Sadile A.G. Dopamine phenotype and behavior in animal models: in relation to attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27 (2003) 623-637
18. Cohen G. Oxy-radical toxicity in catecholamine neurons. Neurotoxicology 5 (1984) 77-82
19. Shapovalova K.B., and Kamkina Y.V. Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors. Neurosci Behav Physiol 38 (2008) 71-79
20. Bishop C., and Walker P.D. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Neuroscience 121 (2003) 649-657
21. Jackson D.M., Anden N.E., Engel J., and Liljequist S. The effect of long-term penifluidol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum. Psychopharmacologia 45 (1975) 151-155
22. Pijnenburg A.J., Honig W.M., Van der Heyden J.A., and Van Rossum J.M. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35 (1976) 45-58
23. Breese G.R., Duncan G.E., Napier T.C., Bondy S.C., Iorio L.C., and Mueller R.A. 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240 (1987) 167-176
24. Barik S., and Beaurepaire R. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Prog Neuro-psychopharmacol Biol Psychiatry 29 (2005) 718-726
25. Schwartz J.C., Griffon N., Diaz J., Levesque D., Sautel F., Sokoloff P., et al. The D3 receptor and its relevance in psychiatry. Int Clin Psychopharmacol Suppl 3 (1995) 15-20
26. Kamei J., and Saitoh A. Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes. Life Sci 59 (1996) 773-780
27. McNamara R.K., Levant B., Taylor B., Ahlbrand R., Liu Y., Sullivan J.R., et al. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice. Neuroscience 143 (2006) 141-153
28. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49 (1997) 231-252
29. Fauchey V., Jaber M., Caron M.G., Bloch B., and Le Moine C. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur J Neurosci 12 (2000) 19-26
30. Zapata A., and Shippenberg T.S. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. J Neurochem 81 (2002) 1035-1042
31. Barili P., Bronzetti E., Ricci A., Zaccheo D., and Amenta F. Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex. Brain Res 854 (2000) 130-138
32. Kolasiewicz W., and Maj J. Locomotor hypoactivity and motor disturbances-behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists. Pol J Pharmacol 53 (2001) 509-515
33. Boyson S.J., McGonigle P., and Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6 (1986) 3177-3188
34. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., and Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564 (1991) 203-219
35. D'Souza U., McGuffin P., and Buckland P.R. Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. Neuropharmacology 36 (1997) 1689-1696
36. Thach W.T., Goodkin H.P., and Keating J.G. The cerebellum and the adaptive coordination of movement. Annu Rev Neurosci 15 (1992) 403-442
37. Thach W.T. Combination, complementarity and automatic control: a role for the cerebellum in learning movement coordination. Novartis Found Symp 218 (1998) 219-228
38. Apps R., and Garwicz M. Anatomical and physiological foundations of cerebellar information processing. Nat Rev Neurosci 4 (2005) 297-311
39. Walter J.T., Alvina K., Womack M.D., Chevez C., and Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 9 (2006) 389-397